Morkin Companies

Morkin Companies is a clinical-stage biotechnology company focused on the development of thyroid hormone analogs for the treatment of cardiovascular diseases. The company's lead research centers on the use of thyroid hormone derivatives to improve cardiac function in patients with heart failure without the typical systemic side effects of thyroid hormones. By targeting specific thyroid hormone receptors in the heart, Morkin Companies aims to provide a novel therapeutic approach for chronic heart conditions. Their work is based on extensive research into the molecular mechanisms of thyroid hormone action on the myocardium.